Back to search

Article

Angelic Acid Prevents RANKL-Induced Osteoclastogenesis Through Pathway-Biased Inhibition of MAPK–NFATc1 Signaling

2026-01-20

Abstract excerpt

<title>Abstract</title> <p> Excessive osteoclast activity drives inflammatory bone loss in osteoporosis, rheumatoid arthritis, and periodontitis. Natural compounds represent promising therapeutic candidates with favorable safety profiles; however, few exhibit pathway-biased mechanisms of action. Here, we report that angelic acid, a naturally occurring unsaturated monocarboxylic acid, potently inhibits RANKL-indu...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d5721051-4ae7-5b52-b07b-4e872d65bf43
DOI
10.21203/rs.3.rs-8630319/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Angelic Acid Prevents RANKL-Induced Osteoclastogenesis Through Pathway-Biased Inhibition of MAPK–NFATc1 SignalingDOI 10.21203/rs.3.rs-8630319/v1
Select a neighboring publication to make it the new centre.